Business Segments · Total other segment expense, net
North American Pharmaceutical — Total other segment expense, net
McKesson North American Pharmaceutical — Total other segment expense, net increased by 1.9% to $87.27B in Q4 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ3 2024
Last reportedQ4 2025
How to read this metric
A decrease relative to revenue indicates improved operational efficiency and better cost control within the segment.
Detailed definition
This metric captures the net total of various operational expenses not directly attributable to the cost of goods sold o...
Peer comparison
Standard segment-level expense reporting found in the financial disclosures of large-scale distribution companies.
Metric ID:
mck_segment_north_american_pharmaceutical_total_other_segment_expense_netHistorical Data
4 periods
| Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|
| Value | $79.67B | $80.45B | $85.63B | $87.27B |
| QoQ Change | — | +1.0% | +6.4% | +1.9% |
| YoY Change | — | — | +7.5% | +8.5% |
Range$79.67B – $87.27B
Avg YoY Growth+8.0%
Median YoY Growth+8.0%
Current Streak3+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's north american pharmaceutical — total other segment expense, net?
- McKesson (MCK) reported north american pharmaceutical — total other segment expense, net of $87.27B in Q4 2025.
- What does north american pharmaceutical — total other segment expense, net mean?
- The net total of miscellaneous operating expenses incurred by the North American Pharmaceutical segment.